UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pharmacokinetics of cefepime after single and multiple intravenous administrations in healthy subjects

Antimicrobial Agents and Chemotherapy, 1992-03, Vol.36 (3), p.552-557

1992

Volltextzugriff (PDF)

Pharmacokinetics of cefepime in subjects with renal insufficiency

Clinical pharmacology and therapeutics, 1990-09, Vol.48 (3), p.268-276

1990

Volltextzugriff (PDF)

Safety, tolerance, and pharmacokinetic evaluation of cefepime after administration of single intravenous doses

Antimicrobial Agents and Chemotherapy, 1990-06, Vol.34 (6), p.1118-1122

1990

Volltextzugriff (PDF)

Effects of age and gender on pharmacokinetics of cefepime

Antimicrobial Agents and Chemotherapy, 1992-06, Vol.36 (6), p.1181-1185

1992

Volltextzugriff (PDF)

Pharmacokinetics of cefepime in patients with the sepsis syndrome

Journal of antimicrobial chemotherapy, 1993-11, Vol.32 (suppl-B), p.117-122

1993

Volltextzugriff (PDF)

Pharmacokinetics of didanosine in patients with acquired immunodeficiency syndrome or acquired immunodeficiency syndrome-related complex

Clinical pharmacology and therapeutics, 1991-05, Vol.49 (5), p.523-535

1991

Volltextzugriff (PDF)

Oral Bioavailability and Disposition of [14C]Omapatrilat in Healthy Subjects

Journal of clinical pharmacology, 2001-08, Vol.41 (8), p.833-841

2001

Volltextzugriff (PDF)

Pharmacokinetics of cefepime in patients undergoing continuous ambulatory peritoneal dialysis

Antimicrobial Agents and Chemotherapy, 1992-07, Vol.36 (7), p.1387-1391

1992

Volltextzugriff (PDF)

Lack of pharmacokinetic interaction between cefepime and amikacin in humans

Antimicrobial Agents and Chemotherapy, 1992-07, Vol.36 (7), p.1382-1386

1992

Volltextzugriff (PDF)

Analysis of potential risk factors associated with the development of pancreatitis in phase I patients with AIDS or AIDS-related complex receiving didanosine

The Journal of infectious diseases, 1994-06, Vol.169 (6), p.1250-1255

1994

Volltextzugriff (PDF)

Disposition of the cephalosporin cefepime in normal and renally impaired subjects

Drug metabolism and disposition, 1991-01, Vol.19 (1), p.68

1991

Volltextzugriff (PDF)

A pharmacokinetic interaction study of didanosine coadministered with trimethoprim and/or sulphamethoxazole in HIV seropositive asymptomatic male patients

British journal of clinical pharmacology, 1996-03, Vol.41 (3), p.207-215

1996

Volltextzugriff (PDF)

Didanosine (ddl) and stavudine (d4T): Absence of peripheral neurotoxicity in rabbits

Food and chemical toxicology, 1995-12, Vol.33 (12), p.1047-1050

1995

Volltextzugriff (PDF)

Food-induced reduction in bioavailability of didanosine

Clinical pharmacology and therapeutics, 1991-11, Vol.50 (5/1), p.503-507

1991

Volltextzugriff (PDF)

Pharmacokinetic-interaction study of didanosine and ranitidine in patients seropositive for human immunodeficiency virus

Antimicrobial Agents and Chemotherapy, 1992-10, Vol.36 (10), p.2075-2079

1992

Volltextzugriff (PDF)

Effect of metoclopramide and loperamide on the pharmacokinetics of didanosine in HIV seropositive asymptomatic male and female patients

European journal of clinical pharmacology, 1993-12, Vol.45 (5), p.409-413

1993

Volltextzugriff (PDF)

A MULTIPLE-DOSE PHARMACOKINETIC INTERACTION STUDY BETWEEN DIDANOSINE (VIDEX®) AND CIPROFLOXACIN (CIPRO®) IN MALE SUBJECTS SEROPOSITIVE FOR HIV BUT ASYMPTOMATIC

Biopharmaceutics & drug disposition, 1997-01, Vol.18 (1), p.65-77

1997

Volltextzugriff (PDF)

Safety, Tolerance, and Pharmacokinetics of Cefepime Administered Intramuscularly to Healthy Subjects

Journal of clinical pharmacology, 1990-10, Vol.30 (10), p.900-910

1990

Volltextzugriff (PDF)

Effect of Time of Food Administration on the Bioavailability of Didanosine From a Chewable Tablet Formulation

Journal of clinical pharmacology, 1993-06, Vol.33 (6), p.568-573

1993

Volltextzugriff (PDF)

Pharmacokinetics of Didanosine and Ketoconazole After Coadministration to Patients Seropositive for the Human Immunodeficiency Virus

Journal of clinical pharmacology, 1993-10, Vol.33 (10), p.912-917

1993

Volltextzugriff (PDF)

Didanosine

Antiviral Chemistry and Chemotherapy, 1991-12, Vol.2 (6), p.321-328

1991

Volltextzugriff (PDF)

Pharmacokinetics of 2',3'-dideoxyinosine (BMY-40900), a new anti-human immunodeficiency virus agent, after administration of single intravenous doses to beagle dogs

Antimicrobial Agents and Chemotherapy, 1991-04, Vol.35 (4), p.610-614

1991

Volltextzugriff (PDF)

Comparative in vitro metabolism of T-2 toxin by hepatic microsomes prepared from phenobarbital-induced or control rats, mice, rabbits and chickens

Food and chemical toxicology, 1987-11, Vol.25 (11), p.859-865

1987

Volltextzugriff (PDF)

Cefepime Pharmacokinetics in Cystic Fibrosis

Pharmacotherapy, 1993-09, Vol.13 (5), p.465-470

1993

Volltextzugriff (PDF)

Isolation and characterization of 4'-hydroxy T-2 toxin, a new metabolite of the trichothecene mycotoxin T-2

Drug metabolism and disposition, 1987-11, Vol.15 (6), p.816

1987

Volltextzugriff (PDF)

1 – 25 von 340

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(284)
Mit Volltextzugriff
(264)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(224)
Life Sciences & Biomedicine
(159)
Humans
(122)
Male
(91)
Biological And Medical Sciences
(77)
Female
(74)
Medical Sciences
(64)
Physical Sciences
(61)
Adult
(50)
Technology
(48)
Pharmacology. Drug Treatments
(44)
Animals
(42)
Pharmacology & Pharmacy
(39)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(36)
Engineering
(34)
Middle Aged
(32)
Thermodynamics
(30)
Adolescent
(28)
Child
(28)
Integral Transforms
(28)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Pharmacokinetics of cefepime after single and multiple intravenous administrations in healthy subjects

Pharmacokinetics of cefepime in subjects with renal insufficiency

Safety, tolerance, and pharmacokinetic evaluation of cefepime after administration of single intravenous doses

Effects of age and gender on pharmacokinetics of cefepime

Pharmacokinetics of cefepime in patients with the sepsis syndrome

Pharmacokinetics of didanosine in patients with acquired immunodeficiency syndrome or acquired immunodeficiency syndrome-related complex

Oral Bioavailability and Disposition of [14C]Omapatrilat in Healthy Subjects

Pharmacokinetics of cefepime in patients undergoing continuous ambulatory peritoneal dialysis

Lack of pharmacokinetic interaction between cefepime and amikacin in humans

Analysis of potential risk factors associated with the development of pancreatitis in phase I patients with AIDS or AIDS-related complex receiving didanosine

Disposition of the cephalosporin cefepime in normal and renally impaired subjects

A pharmacokinetic interaction study of didanosine coadministered with trimethoprim and/or sulphamethoxazole in HIV seropositive asymptomatic male patients

Didanosine (ddl) and stavudine (d4T): Absence of peripheral neurotoxicity in rabbits

Food-induced reduction in bioavailability of didanosine

Pharmacokinetic-interaction study of didanosine and ranitidine in patients seropositive for human immunodeficiency virus

Effect of metoclopramide and loperamide on the pharmacokinetics of didanosine in HIV seropositive asymptomatic male and female patients

A MULTIPLE-DOSE PHARMACOKINETIC INTERACTION STUDY BETWEEN DIDANOSINE (VIDEX®) AND CIPROFLOXACIN (CIPRO®) IN MALE SUBJECTS SEROPOSITIVE FOR HIV BUT ASYMPTOMATIC

Safety, Tolerance, and Pharmacokinetics of Cefepime Administered Intramuscularly to Healthy Subjects

Effect of Time of Food Administration on the Bioavailability of Didanosine From a Chewable Tablet Formulation

Pharmacokinetics of Didanosine and Ketoconazole After Coadministration to Patients Seropositive for the Human Immunodeficiency Virus

Didanosine

Pharmacokinetics of 2',3'-dideoxyinosine (BMY-40900), a new anti-human immunodeficiency virus agent, after administration of single intravenous doses to beagle dogs

Comparative in vitro metabolism of T-2 toxin by hepatic microsomes prepared from phenobarbital-induced or control rats, mice, rabbits and chickens

Cefepime Pharmacokinetics in Cystic Fibrosis

Isolation and characterization of 4'-hydroxy T-2 toxin, a new metabolite of the trichothecene mycotoxin T-2

Suchergebnisse filtern